Fluoroquinolone-resistant uropathogenic Escherichia coli in Norway: Evidence of clonal spread

Clinical Microbiology and Infection

Volumn 14, Issue 5, 2008, Pages 498-500

  Grude, Nils ^a   Strand, L ^a   Mykland, H ^b   Nowrouzian, F L ^c   Nyhus, J ^d   Jenkins, A ^a   Kristiansen, B E ^a,e  

^a Telemark Biomedical Centre   (Norway)

^b UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d Bionor Immuno AS   (Norway)

^e UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Clonal spread; Esherichia coli; Flouroquinolone resistance; Phylogroups; Urinary tract infection; Virulence factors

Indexed keywords

AMPICILLIN; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; GENTAMICIN; MECILLINAM; NALIDIXIC ACID; NITROFURANTOIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; VIRULENCE FACTOR;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; FEMALE; GENETIC COMPLEMENTATION; GENETIC HETEROGENEITY; HUMAN; MALE; NONHUMAN; NORWAY; PREVALENCE; PRIORITY JOURNAL; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ESCHERICHIA COLI;

EID: 41949093961     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.01952.x     Document Type: Article

References (16)

1. Drews SJ, Poutanen SM, Mazzulli T et al. Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates. J Clin Microbiol 2005; 43: 4218-4220.
2. Garau J, Xercavins M, Rodriguez-Carballeira M et al. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother 1999; 43: 2736-2741.
3. Anonymous. NORM/NORM-VET 2006. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. Tromsø: National Veterinary Institute, 2007.
4. Anonymous. EARSS annual report 2005. Bilthoven: EARSS, 2006.
5. Grude N, Tveten Y, Kristiansen B-E. Urinary tract infections in Norway; bacterial etiology and susceptibility. A retrospective study of clinical isolates. Clin Microbiol Infect 2001; 7: 543-547.
6. Johnson JR, van der Schee C, Kuskowski MA et al. Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands. J Infect Dis 2002; 186: 1852-1856.
7. Moreno E, Prats G, Sabate M et al. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J Antimicrob Chemother 2006; 57: 204-211.
8. Velasco M, Horcajada JP, Mensa J et al. Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis 2001; 33: 1682-1686.
9. Kuntaman K, Lestari ES, Severin JA et al. Fluoroquinolone-resistant Escherichia coli, Indonesia. Emerg Infect Dis 2005; 11: 1363-1369.
10. Grude N, Potaturkina-Nesterova NI, Jenkins A et al. A comparison of phylogenetic group, virulence factors and antibiotic resistance in Russian and Norwegian isolates of Escherichia coli from urinary tract infection. Clin Microbiol Infect 2007; 13: 208-211.
11. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
12. Manges AR, Johnson JR, Foxman B et al. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 2001; 345: 1007-1013.
13. Karlowsky JA, Hoban DJ, DeCorby MR et al. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: Results from the North-American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance Study. Antimicrob Agents Chemother 2006; 50: 2251-2254.
14. Johnson JR, Moseley SL, Roberts PL et al. Aerobactin and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics. Infect Immun 1988; 56: 405-412.
15. Vila J, Simon K, Ruiz J et al. Are quinolone-resistant uropathogenic Escherichia coli less virulent? J Infect Dis 2002; 186: 1039-1042.
16. Ramchandani M, Manges AR, DebRoy C et al. Possible animal origin of human associated, multidrug-resistant, uropathogenic Escherichia coli. Clin Infect Dis 2005; 40: 251-257.